NHS England announced in May that it would introduce a pioneering liquid biopsy blood test, offering new hope to lung and breast cancer patients.
The innovative test is a world-first, and analyses tumour DNA fragments circulating in the bloodstream, enabling doctors to prescribe personalised treatments more swiftly. It is expected that 15,000 patients will benefit from the rollout each year.
